SOD2 and head and neck squamous cell carcinoma: Collectively, our data demonstrate that TAMs confer DTX resistance in HNSCC via secretion of IL-1β, which activates SOD2 and inhibits CAT to modulate intracellular ROS levels, thereby increasing ICAM1 expression in HNSCC.